Head-to-head · Cost-Efficiency Index
Gatlan vs Medi-Weightloss
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Gatlan
Cost-first shoppers who want named clinical leadership (Dr. Robert Lufkin) over transparent per-dose pricing, which the site does not publish.
Visit GatlanMedi-Weightloss
Shoppers near one of Medi-Weightloss's 130+ US clinics who want in-person labs and are comfortable with location-dependent pricing.
Visit Medi-WeightlossThe verdict
Gatlan and Medi-Weightloss tie on the Cost-Efficiency Index at 54/100, so neither wins outright on the numbers. For most shoppers we'd start with Gatlan (ranked #354, a hair above #358) — Cost-first shoppers who want named clinical leadership (Dr. Robert Lufkin) over transparent per-dose pricing, which the site does not publish. But Medi-Weightloss is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Gatlan.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Gatlan | Medi-Weightloss |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 54/100 |
| Semaglutide / mo | Not disclosed | $99/mo (starting dose, first-month rate, plus a separate fee, compounded) |
| Tirzepatide / mo | $199/mo (starting dose, compounded) | $199/mo (starting dose, first-month rate, plus a separate fee, compounded) |
| Semaglutide / yr (modeled) | — | $1,188 |
| Tirzepatide / yr (modeled) | $2,388 | $2,388 |
| Coverage | 44 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #354 | #358 |
Gatlan
54/100Where the value is
- Named Chief Medical Advisor with verifiable academic credentials — Dr. Robert Lufkin, UCLA/USC
- 44 states are listed by name in the footer, so coverage can be checked without starting sign-up
- A real 'From $199/mo' price point is published without requiring signup, even though it isn't broken out by drug or dose
The tradeoffs
- The '$199/mo' figure is a bare 'starting at' number — no dose, no named drug, and no indication of what happens to price at higher doses
- No LegitScript badge found on any page reached
Medi-Weightloss
54/100Where the value is
- Over 130 in-person clinic locations across the US with on-site labs and body composition analysis at the new-patient visit
- Publishes real introductory numbers ($99 semaglutide / $199 tirzepatide first month) rather than staying fully opaque
- Insurance path available for branded Zepbound/Wegovy/Saxenda, with the site claiming most insured patients 'pay between $0 and $50 per visit'
The tradeoffs
- The $99/$199 headline figures are explicitly FIRST-MONTH-ONLY; the ongoing self-pay rate 'varies by program and location' and is never published anywhere on the site
- A separate $199 new-patient visit fee is charged before the first month's medication price even applies
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.